Collegium Pharmaceutical (COLL) Research & Development (2014 - 2022)
Collegium Pharmaceutical (COLL) posted quarterly Research & Development of $4.0 million for Q1 2022, up 35.94% year-over-year from $2.9 million in Q1 2021, and up 147.55% quarter-over-quarter from $1.6 million in Q4 2021.
Collegium Pharmaceutical (COLL) Research & Development (2014 - 2022) Analysis & Trends
Collegium Pharmaceutical's Research & Development history runs 9 years deep, the most recent figure standing at $4.0 million for Q1 2022.
- In Q1 2022, Research & Development rose 35.94% year-over-year to $4.0 million; the TTM figure through Dec 2022 stood at $4.0 million (down 57.86% YoY), while the FY2022 annual figure was $4.0 million, down 57.86% from the prior year.
- Research & Development for Q1 2022 stood at $4.0 million, up from $1.6 million in the prior quarter.
- The five-year high for Research & Development was $4.0 million in Q1 2022, with the low at $1.4 million in Q3 2021.
- The 5-year median for Research & Development is $2.5 million (2019), against an average of $2.5 million.
- Peak annual rise in Research & Development reached 38.87% in 2021, while the deepest fall reached 34.91% in 2021.
- Collegium Pharmaceutical's Research & Development stood at $2.2 million in 2018, then rose by 6.63% to $2.4 million in 2019, then increased by 3.09% to $2.5 million in 2020, then slumped by 34.91% to $1.6 million in 2021, then soared by 147.55% to $4.0 million in 2022.
- Business Quant data shows COLL's Research & Development at $4.0 million in Q1 2022, $1.6 million in Q4 2021, and $1.4 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Collegium Pharmaceutical | 889.75 Mn | 740.43 Mn | 110.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 3.98 Mn |
| Dec 31, 2021 | 1.61 Mn |
| Sep 30, 2021 | 1.45 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Mar 31, 2021 | 2.93 Mn |
| Dec 31, 2020 | 2.47 Mn |
| Sep 30, 2020 | 2.14 Mn |
| Jun 30, 2020 | 2.49 Mn |
| Mar 31, 2020 | 2.67 Mn |
| Dec 31, 2019 | 2.40 Mn |
| Sep 30, 2019 | 2.49 Mn |
| Jun 30, 2019 | 2.46 Mn |
| Mar 31, 2019 | 2.99 Mn |
| Dec 31, 2018 | 2.25 Mn |
| Sep 30, 2018 | 1.91 Mn |
| Jun 30, 2018 | 2.24 Mn |
| Mar 31, 2018 | 2.27 Mn |
| Dec 31, 2017 | 2.19 Mn |
| Sep 30, 2017 | 2.07 Mn |
| Jun 30, 2017 | 2.18 Mn |